Three insect neurotoxins from the scorpion Buthus martensii Karsch, named BmK I1, BmK I4 and BmK I6, have been puri®ed and crystallized. BmK I1 and BmK I4 show strong toxicity to insects, while BmK I6 is relatively weaker. They all exhibit an evident analgesic effect on mice; this is a novel biological function for scorpion insect toxins. Their crystals diffract to at least 3.5 (BmK I1), 2.8 (BmK I4), 2.8 (BmK I6 crystal form I) and 2.2 A Ê (of BmK I6 crystal form II) resolution on an ordinary X-ray source. Crystals of BmK I1 belong to space group P6, with unit-cell parameters a = b = 66.2, c = 176.7 A Ê . BmK I4 crystallized in the tetragonal space group I4, with unit-cell parameters a = b = 134.5, c = 60.6 A Ê . BmK I6 has been crystallized in two forms: form I belongs to space group C2, with unit-cell parameters a = 46.5, b = 85.2, c = 32.6 A Ê , = 110.5 ; form II belongs to space group R3, with the hexagonal unit-cell parameters a = b = 44.5, c = 164.7 A Ê .
Introduction
Scorpion venoms are rich sources of various neurotoxins that bind to ionic channels at the surface of excitable cells and diversely modify their normal properties. These toxins are speci®c to mammals, insects and crustaceans (Possani, 1984; Gordon et al., 1998) . The toxins directed at insects are referred to as`insect toxins' in this paper. Long-chain insect toxins, containing 60±80 residues, are able to bind to insect sodium channels (Gordon et al., 1992; Zlotkin et al., 1995) . The investigation of these insect toxins is of great value from both academic and applicational viewpoints, in particular the investigation of the mechanism of their binding to sodium channels (Gordon, 1997) . These potent toxins are an invaluable tool in developing pest-controlling transgenic plants and designing insecticides with higher performance and fewer side effects (Stewart et al., 1991; Gurevitz et al., 1996; Gershburg et al., 1997) . Therefore, the elucidation of the insect toxins' three-dimensional structures and structure±function relationship are of importance.
Recently, we obtained three insect toxins, BmK I1, I4 and I6, from the venom of the scorpion B. martensii Karsch (BmK), widely distributed in China, which displayed a 50-fold range in anti-insect toxicity in vivo. Very interestingly, these toxins display evident analgesic effects but are devoid of any toxicity to mice as shown by bioassay; this has never previously been reported for scorpion insect toxins. The analgesic activities of the three toxins are also different. Therefore, this series of BmK scorpion toxins forms a valuable bioactivity-distinctive system. Though all analgesic chemicals in common use, such as morphine, heroin and barbitone, are effective, they also have side effects, especially the addictive narcotic drugs. If the mechanism of the analgesic effect of this series of BmK toxins is elucidated, a small peptide designed to mimic such toxins should aid in the search for a potential medicine for analgesia without the danger of addiction. Because of this, the threedimensional structures of the BmK toxins are of great signi®cance.
Since the ®rst insect toxin, AaH IT, was puri®ed (Zlotkin et al., 1971 ), many such toxins have been puri®ed and characterized (Possani et al., 1999) . However, until now only one crystal structure of an insect toxin, Bj-xtrIT (Oren et al., 1998) , has been reported. Fortunately, the three BmK toxins described above have been crystallized in our laboratory. Furthermore, the gene encoding BmK I4 has been cloned (Xiong et al., 1999) and expressed (unpublished results). Obviously, the next step is the three-dimensional structure determination. Here, we report the crystallization and preliminary X-ray analyses of these three toxins.
Experiments and results

Purification and characterization
BmK I1, BmK I4 and BmK I6 were puri®ed from the venom of BmK scorpions from the Henan Province of China. The typical puri®cation procedure is similar to that described crystallization papers previously (Xiong et al., 1999) . The products were analyzed on a C8 reverse-phase column on the A È KTA Puri®er system (Pharmacia, Sweden), which showed that all the resulting toxins possessed purities of higher than 90%. Compared with other insect toxins, these three toxins are rather acidic; their isoelectric points (pI) are 4.0, 4.3 and 6.5 for BmK I1, I4 and I6, respectively, as determined by isoelectrofocusing PAGE. The molecular masses of BmK I1, I4 and I6 obtained from the MALDI±TOF mass spectrum on a BIFLEX III-MS System (Bruke, USA) are 8141.0, 8149.3 and 6722.2 Da, respectively. Analysis of amino-acid components showed BmK I1, I4 and I6 contained 72, 72 and 61 resi-dues; they are all crosslinked by four disul-®de bridges. The full sequence of BmK I4 has been determined by protein analysis and cDNA sequencing (Xiong et al., 1999) . The sequence shows about 61% homology with that of Bj-xtrIT from the scorpion Buthotus judaicus (Fig. 1) . At the present time, only 15 residues at the N-terminals of BmK I1 and I6 have been sequenced; their cDNA clonings are in progress.
The insect-speci®c toxicities of the puri-®ed toxins were tested on the larvae of house¯ies weighing about 30 mg, as described previously (Zlotkin et al., 1985; Xiong et al., 1999) . The CPU (contraction paralysis unit) was de®ned as the acute dose that caused half of the recipient larvae to contract in 5 s. The toxins strongly induced a sustained contraction paralysis when injected into the¯y larvae and their CPU values were 0.02, 0.01 and 0.5 mg per body for BmK I1, I4 and I6, respectively. Their relative toxicities are 25:50:1. They all also displayed an obvious analgesic effect on mice. The analgesic activity was assessed by a mouse-twisting model (Fennessy & Lee, 1975 ) using a procedure reported previously (Xiong et al., 1999) . At a dose of 1 mg kg À1 , BmK I4 exhibited a 54.4% inhibition of the mouse-twisting reaction; however, BmK I1 and I6 exhibited 47.0 and 42.7% inhibition ef®ciency, respectively, at a dose of 5 mg kg À1 . When using a painkiller (Tranquilizer), a dose of 80 mg kg À1 only displayed 62.4% inhibition, which was much less potent than these toxins. Interestingly, when 10 mg kg À1 toxins were injected into mouse through its tail vein, no paralytic symptoms were observed. Thus, these toxins were devoid of mammalian neurotoxicity.
Crystallization
Initially, the Crystal Screen and Crystal Screen II kits (Hampton Research, USA) were used to screen the initial crystallizing conditions for BmK I1, BmK I4 and BmK I6; however, no crystals were found. With the solubility information provided by the screening experiments, a wide range of precipitants and pH values were tried using the grid-screen method (Samudzi & Fivash, 1992) . After optimization of the conditions under which crystals appeared, good single crystals suitable for diffraction of these toxins were ®nally obtained (Fig. 2) . The detailed crystallization conditions are listed in Table 1 . It should be mentioned that in the crystallization of BmK I4, lowering the dioxane concentration to slightly below 5% led to the appearance of another crystal crystallization papers form of hexagonal shape which showed very weak X-ray diffraction.
X-ray crystallographic analyses
The best single crystals of BmK I1, BmK I4 and BmK I6 were selected for use in data collection. The sizes of the crystals used are listed in Table 1 . All diffraction data were collected at room temperature on a 345 mm MAR Research imaging-plate detector using Cu K radiation (! = 1.5418 A Ê ) from a generator operating at 40 kV and 50 mA. The programs DENZO and SCALEPACK (Otwinowski & Minor, 1997) were used for data processing and analysis. The Matthews coef®cients and solvent contents were calculated using the Matthews equation (Matthews, 1968) . The results are listed in Table 2 . The structure determination of BmK I1 and I4 are currently under way using the molecular-replacement method, with the structure of Bj-xtrIT (PDB code 1bcg) as the initial model. 
